JRPIM
GILD icon

Journey Retirement Planning & Investment Management’s Gilead Sciences GILD Stock Holding History

Journey Retirement Planning & Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Buy
8,972
+137
+2% +$18.1K 0.88% 21
2026
Q1 		$1.23M Sell
8,835
-25,421
-74% -$3.56M 1.08% 17
2025
Q4 		$4.2M Buy
+34,256
New +$4.16M 0.86% 23

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Journey Retirement Planning & Investment Management's GILD Position: Q2 2026 in Review

Journey Retirement Planning & Investment Management increased its Gilead Sciences (GILD) stake by 1.6% in Q2 2026, buying an estimated $18.1K and bringing the position to 8,972 shares worth $1.13M. The position accounts for 0.88% of the portfolio, ranked #21.

Journey Retirement Planning & Investment Management first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.2M in Q4 2025. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Journey Retirement Planning & Investment Management held 8,972 shares of Gilead Sciences worth $1.13M as of Q2 2026.
  • Journey Retirement Planning & Investment Management bought 137 Gilead Sciences shares in Q2 2026, an estimated $18.1K.
  • Gilead Sciences made up 0.88% of Journey Retirement Planning & Investment Management's portfolio in Q2 2026, its #21 holding.
  • Journey Retirement Planning & Investment Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Journey Retirement Planning & Investment Management's Gilead Sciences position peaked at $4.2M in Q4 2025.
  • 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Journey Retirement Planning & Investment Management's 13F filing for Q2 2026, filed 24 Jul 2026.